v3.23.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2023
Dec. 31, 2022
CURRENT ASSETS:    
Cash $ 653,191 $ 1,990,910
Rent receivable 136,053 134,626
Prepaid expense and other current assets 633,510 247,990
Total Current Assets 1,422,754 2,373,526
NON-CURRENT ASSETS:    
Operating lease right-of-use assets, net 187,702 10,885
Property and equipment, net 117,466 138,294
Investment in real estate, net 7,275,746 7,360,087
Equity method investments, net 21,355,134 485,008
Advances for equity interest purchase 8,999,722
Other non-current assets 211,782 384,383
Total Non-current Assets 29,147,830 17,378,379
Total Assets 30,570,584 19,751,905
CURRENT LIABILITIES:    
Accrued professional fees 1,685,448 1,673,411
Accrued research and development fees 900,473 838,001
Accrued payroll liability and compensation 294,921 223,722
Accrued litigation settlement 450,000 450,000
Accrued liabilities and other payables 278,209 283,234
Accrued liabilities and other payables - related parties 117,701 100,000
Operating lease obligation 121,486 11,437
Equity method investment payable 1,000,000
Derivative liability 97,095  
Convertible note payable, net 1,019,899  
Total Current Liabilities 5,965,232 3,579,805
NON-CURRENT LIABILITIES:    
Operating lease obligation - noncurrent portion 67,434
Accrued litigation settlement - noncurrent portion   450,000
Note payable, net 5,536,605 4,563,152
Loan payable - related party 850,000
Total Non-current Liabilities 6,454,039 5,013,152
Total Liabilities 12,419,271 8,592,957
Commitments and Contingencies (Note 15)
EQUITY:    
Preferred stock value
Common stock, $0.0001 par value; 490,000,000 shares authorized; 10,499,907 shares issued and 10,447,907 shares outstanding at June 30, 2023; 10,013,576 shares issued and 9,961,576 shares outstanding at December 31, 2022 1,050 1,005
Additional paid-in capital 67,276,611 65,949,723
Less: common stock held in treasury, at cost; 52,000 shares at June 30, 2023 and December 31, 2022 (522,500) (522,500)
Accumulated deficit (68,389,948) (63,062,721)
Statutory reserve 6,578 6,578
Accumulated other comprehensive loss (220,478) (213,137)
Total Avalon GloboCare Corp. stockholders’ equity 18,151,313 11,158,948
Non-controlling interest
Total Equity 18,151,313 11,158,948
Total Liabilities and Equity 30,570,584 19,751,905
Series A Convertible Preferred Stock    
EQUITY:    
Preferred stock value 9,000,000 9,000,000
Series B Convertible Preferred Stock    
EQUITY:    
Preferred stock value $ 11,000,000

Source

PDF HTML
ZIP